Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study

INTRODUCTION: The dynamic range of cerebrospinal fluid (CSF) amyloid β (Aβ(1–42)) measurement does not parallel to cognitive changes in Alzheimer's disease (AD) and cognitively normal (CN) subjects across different studies. Therefore, identifying novel proteins to characterize symptomatic AD sa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Alzheimers Dement (Amst)
Autori principali: Leung, Yuk Yee, Toledo, Jon B., Nefedov, Alexey, Polikar, Robi, Raghavan, Nandini, Xie, Sharon X., Farnum, Michael, Schultz, Tim, Baek, Young, Van Deerlin, Vivianna M., Hu, William T., Holtzman, David M., Fagan, Anne M., Perrin, Richard J., Grossman, Murray, Soares, Holly D., Kling, Mitchel A., Mailman, Matthew, Arnold, Steven E., Narayan, Vaibhav A., Lee, Virginia M-Y., Shaw, Leslie M., Baker, David, Wittenberg, Gayle M., Trojanowski, John Q., Wang, Li-San
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2015
Soggetti:
CSF Biomarkers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4672388/
https://ncbi.nlm.nih.gov/pubmed/26693175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.06.008
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi